Jilin Jian Yisheng Pharmaceutical Co., Ltd. (SHE:002566)

SHE:002566 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Net Income	33.28	29	52.09	94.73	83.1	96.02
Depreciation & Amortization	42.7	42.7	47.08	48.93	44.27	43.09
Other Amortization	0.68	0.68	0.63	1.53	0.92	1.18
Loss (Gain) From Sale of Assets	-0.4	-0.4	-0.29	-0.78	-	-
Asset Writedown & Restructuring Costs	0.3	0.3	0.27	0.24	0.27	0.28
Loss (Gain) From Sale of Investments	-9.53	-9.53	-11.98	-4.02	-2.62	-0.25
Provision & Write-off of Bad Debts	2.13	2.13	-0.23	-	1.27	-0.46
Other Operating Activities	20.88	15.6	14.26	10.88	19.99	22.41
Change in Accounts Receivable	-29.65	-29.65	5.21	75.22	-17.02	-31.92
Change in Inventory	43.03	43.03	-11.33	-12.65	-4.99	17.85
Change in Accounts Payable	8.01	8.01	-37.26	-7.09	18.54	64.21
Operating Cash Flow	108.3	98.74	58.94	209.13	145.86	215.1
Operating Cash Flow Growth	183.45%	67.51%	-71.81%	43.38%	-32.19%	5.69%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Capital Expenditures	-7.41	-13.64	-15.94	-35.77	-41.36	-107.07
Sale of Property, Plant & Equipment	0.12	0.28	0.45	0.74	-	0
Investment in Securities	68.26	-51.76	-365	-40	40	-100
Other Investing Activities	14.71	11.71	5.29	1.64	3.13	-
Investing Cash Flow	75.68	-53.42	-375.21	-73.39	1.77	-207.06

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Short-Term Debt Issued	-	20	-	-	430	397.45
Long-Term Debt Issued	-	333	600	520	-	-
Total Debt Issued	348	353	600	520	430	397.45
Short-Term Debt Repaid	-	-	-	-	-400	-415
Long-Term Debt Repaid	-	-360.64	-638.35	-484.84	-3.06	-5.75
Total Debt Repaid	-355.64	-360.64	-638.35	-484.84	-403.06	-420.75
Net Debt Issued (Repaid)	-7.64	-7.64	-38.35	35.16	26.94	-23.3
Common Dividends Paid	-45.02	-45.61	-61.64	-29.86	-	-23.32
Other Financing Activities	-7.31	-	-	3.43	-50.99	-28.72
Financing Cash Flow	-59.96	-53.25	-99.99	8.73	-24.06	-75.34

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Foreign Exchange Rate Adjustments	0	0	-0	-	-	-
Net Cash Flow	124.02	-7.93	-416.25	144.47	123.57	-67.3

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Free Cash Flow	100.89	85.1	43	173.36	104.49	108.04
Free Cash Flow Growth	264.38%	97.89%	-75.19%	65.91%	-3.28%	-15.32%
Free Cash Flow Margin	15.29%	13.29%	6.43%	20.31%	12.59%	12.31%
Free Cash Flow Per Share	0.30	0.26	0.13	0.52	0.32	0.33
Levered Free Cash Flow	69.12	54.51	9.65	94.72	77.27	5.5
Unlevered Free Cash Flow	76.92	62.4	18.3	103.26	86.04	13.85

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash Income Tax Paid	90.04	89.77	96.65	113.44	100.26	98.63
Change in Working Capital	18.26	18.26	-42.87	57.63	-1.34	52.82

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 4, 2026

Data Sources Report a data error